Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BML-284

😃Good
Hot
Catalog No. T3144Cas No. 853220-52-7
Alias Wnt agonist 1

BML-284 (Wnt agonist 1) is a potent, selective and , cell-permeable Wnt signaling activator.

BML-284

BML-284

😃Good
Hot
Purity: 99.92%
Catalog No. T3144Alias Wnt agonist 1Cas No. 853220-52-7
BML-284 (Wnt agonist 1) is a potent, selective and , cell-permeable Wnt signaling activator.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$55In StockIn Stock
10 mg$80In StockIn Stock
25 mg$143In StockIn Stock
50 mg$266In StockIn Stock
100 mg$450In StockIn Stock
200 mg$648-In Stock
500 mg$987-In Stock
1 mL x 10 mM (in DMSO)$61In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.92%
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
BML-284 (Wnt agonist 1) is a potent, selective and , cell-permeable Wnt signaling activator.
Targets&IC50
TCF-dependent transcriptional activity:700 nM (EC50)
In vitro
Wnt agonist 1 does not inhibit the activity of GSK-3β, and may be a useful tool in the study of physiological processes that involve the Wnt pathway. [1]
In vivo
In a Xenopus model, Wnt agonist 1 (10 μM) mimics the effects of Wnt at the whole-organism level, and affects Xenopus embryonic head specification. [1]
SynonymsWnt agonist 1
Chemical Properties
Molecular Weight350.37
FormulaC19H18N4O3
Cas No.853220-52-7
SmilesCOc1cccc(c1)-c1cc(NCc2ccc3OCOc3c2)nc(N)n1
Relative Density.1.353 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 255 mg/mL (727.8 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.71 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8541 mL14.2706 mL28.5413 mL142.7063 mL
5 mM0.5708 mL2.8541 mL5.7083 mL28.5413 mL
10 mM0.2854 mL1.4271 mL2.8541 mL14.2706 mL
20 mM0.1427 mL0.7135 mL1.4271 mL7.1353 mL
50 mM0.0571 mL0.2854 mL0.5708 mL2.8541 mL
100 mM0.0285 mL0.1427 mL0.2854 mL1.4271 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BML-284 | purchase BML-284 | BML-284 cost | order BML-284 | BML-284 chemical structure | BML-284 in vivo | BML-284 in vitro | BML-284 formula | BML-284 molecular weight